Abstract:BACKGROUND The xeroderma pigmentosum group G (XPG) gene at chromosome 13q33 consists of 15 exons, which may be related to the occurrence and development of gastric cancer (GC). AIM To examine the association of several common single nucleotide polymorphisms (SNPs) of the XPG gene with GC risk and survival. METHODS Five SNPs of XPG (rs2094258, rs751402, rs873601, rs2296147, and rs1047768) were genotyped by PCR restriction fragment length polymorphism in 956 histologically confirmed GC cases and 1012 controls in North China. GC patients were followed for survival status and, if deceased, cause of death. Logistic regression and Cox regression were used for analysing associations of XPG SNPs with risk of GC and prognosis, respectively. For rs2094258, heterozygous model (CT vs CC), homozygous model (TT vs CC), recessive model (TT vs CT + CC), and dominant model (TT + CT vs CC) were analyzed. RESULTS None of the examined loci were statistically associated with GC risk, although rs2296147 was marginally associated with GC risk (P = 0.050). GC patients with the rs2094258 CT + CC genotype showed worse survival than those with the TT genotype (log-rank test, P = 0.028), and patients with the CC genotype had a tendency of unfavourable prognosis compared with those with the TT + CT genotype (log-rank test, P = 0.039). The increase in C alleles of rs2094258 [hazard ratio (HR) = 1.19, 95% confidence interval (CI): 1.02-1.45, P = 0.037] were associated with the long-term survival of GC cases. Other risk factors for survival included tumor differentiation (HR = 4.51, 95% CI: 1.99-8.23, P < 0.001), lymphovascular invasion (HR = 1.97, 95% CI: 1.44-3.01, P < 0.001), and use of chemotherapy (HR = 0.81, 95% CI: 0.63-0.98, P = 0.041). CONCLUSION The XPG rs2094258 polymorphism may be associated with overall survival in GC patients.

Xeroderma Pigmentosum Complementation Group F Polymorphisms Influence Risk of Glioma

[Association of XPC gene polymorphisms with breast cancer risk].

Effect of CDKN2A/B rs4977756 polymorphism on glioma risk: a meta-analysis of 16 studies including 24077 participants

XPG Gene Polymorphisms and Cancer Susceptibility: Evidence from 47 Studies.

Impact of XPF Rs2276466 Polymorphism on Cancer Susceptibility: a Meta-Analysis.

Three Polymorphisms of DNA Repair Gene XRCC1 and the Risk of Glioma: a Case–control Study in Northwest China

XPG Gene Polymorphisms Contribute to Colorectal Cancer Susceptibility: A Two-Stage Case-Control Study.

Association of XPG Rs2094258 Polymorphism with Gastric Cancer Prognosis

XRCC 4 rs 1805377 polymorphism increases glioma risk in Asian populations

Xrcc3 Haplotypes and Risk of Gliomas in A Chinese Population: A Hospital-Based Case-Control Study

Quantitative assessment of the association between XRCC6 C1310G polymorphism and cancer risk

Association Between XRCC1 Arg399Gln Polymorphism and Glioma Risk in a Chinese Population: a Case-Control Study.

A Case-Control Study of the Association Between the EGFR Gene and Glioma Risk in a Chinese Han Population

Association of genetic polymorphisms of EGFR with glioma in a Chinese population.

Association Between Xpf Polymorphisms And Cancer Risk: A Meta-Analysis

XPF-673C>T Polymorphism Effect on the Susceptibility to Esophageal Cancer in Chinese Population.

Genetic polymorphisms of DNA double-strand break repair pathway genes and glioma susceptibility

Association Between Genetic Variants in the XPG Gene and Gastric Cancer Risk in a Southern Chinese Population

Effect of Xeroderma pigmentosum complementation group F polymorphisms on gastric cancer risk and associations with H.pylori infection

Genetic Variation In The Egfr Gene And The Risk Of Glioma In A Chinese Han Population

Genetic Variants in XPD Gene and Glioma Susceptibility in Chinese Children: A Multicenter Case–control Study